keyword
https://read.qxmd.com/read/38652829/nanoparticle-retinoic-acid-inducible-gene-i-agonist-for-cancer-immunotherapy
#1
JOURNAL ARTICLE
Lihong Wang-Bishop, Mohamed Wehbe, Lucinda E Pastora, Jinming Yang, Blaise R Kimmel, Kyle M Garland, Kyle W Becker, Carcia S Carson, Eric W Roth, Katherine N Gibson-Corley, David Ulkoski, Venkata Krishnamurthy, Olga Fedorova, Ann Richmond, Anna Marie Pyle, John T Wilson
Pharmacological activation of the retinoic acid-inducible gene I (RIG-I) pathway holds promise for increasing tumor immunogenicity and improving the response to immune checkpoint inhibitors (ICIs). However, the potency and clinical efficacy of 5'-triphosphate RNA (3pRNA) agonists of RIG-I are hindered by multiple pharmacological barriers, including poor pharmacokinetics, nuclease degradation, and inefficient delivery to the cytosol where RIG-I is localized. Here, we address these challenges through the design and evaluation of ionizable lipid nanoparticles (LNPs) for the delivery of 3p-modified stem-loop RNAs (SLRs)...
April 23, 2024: ACS Nano
https://read.qxmd.com/read/38652814/immunologic-profiling-of-immune-related-cutaneous-adverse-events-with-checkpoint-inhibitors-reveals-polarized-actionable-pathways
#2
JOURNAL ARTICLE
Mario E Lacouture, Elena Goleva, Neil Shah, Veronica Rotemberg, Lukas Kraehenbuehl, Kwami F Ketosugbo, Taha Merghoub, Tara Maier, Alexander Bang, Stephanie Gu, Trina Salvador, Andrea P Moy, Taras Lyubchenko, Olivia Xiao, Clifton F Hall, Evgeny Berdyshev, James Crooks, Ryan Weight, Jeffrey A Kern, Donald Y M Leung
PURPOSE: Immune-related cutaneous adverse events (ircAEs) occur in ≥50% of patients treated with checkpoint inhibitors (CPI), but mechanisms are poorly understood. EXPERIMENTAL DESIGN: Phenotyping/biomarker analyses were conducted in 200 patients on CPIs (139 with ircAEs, 61 without, control) to characterize their clinical presentation and immunologic endotypes. Cytokines were evaluated in skin biopsies, skin tape strip (STS) extracts and plasma using real-time PCR and Meso Scale Discovery multiplex cytokine assays...
April 23, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38652812/genomic-profiling-to-contextualize-the-results-of-intervention-for-smoldering-multiple-myeloma
#3
JOURNAL ARTICLE
Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, Elizabeth Hill, Romanos Sklavenitis-Pistofidis, Bachisio Ziccheddu, Patrick Blaney, Monika Chojnacka, Michael Durante, Kylee Maclachlan, Ryan Young, Saad Usmani, Faith Davies, Gad Getz, Irene Ghobrial, Neha Korde, Gareth Morgan, Francesco Maura, Ola Landgren
PURPOSE: Early intervention for High-Risk Smoldering Multiple Myeloma (HR-SMM) achieves deep and prolonged responses. It is unclear if beneficial outcomes are due to treatment of less complex, susceptible disease or inaccuracy in clinical definition of cases entered. EXPERIMENTAL DESIGN: Here, we interrogated whole genome and whole exome sequencing for 54 patients across two HR-SMM interventional studies (NCT01572480, NCT02279394). RESULTS: We reveal that the genomic landscape of treated HR-SMM is generally simple as compared to Newly Diagnosed (ND)MM counterparts with less inactivation of tumor suppressor genes, RAS pathway mutations, MYC disruption, and APOBEC contribution...
April 23, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38652670/two-decades-of-department-of-veterans-affairs-traumatic-brain-injury-care-and-benefits-for-veterans-of-post-9-11-conflicts
#4
JOURNAL ARTICLE
Gale Whiteneck, William Williams, Emily Almeida, Douglas Bidelspach, William Culpepper, Linda M Picon, C B Eagye, David Dr Mellick
OBJECTIVE: To describe the background, methodology, and results of the congressionally mandated Department of Veterans Affairs (VA) Traumatic Brain Injury (TBI) Veterans Health Registry. SETTING: Veterans Health Administration (VHA) and Veterans Benefit Administration (VBA). PARTICIPANTS: A total of 441 639 Veterans of post-9/11 conflicts who exhibited symptoms associated with TBI and sought care or benefits from the VA between September 2001 and September 2021...
April 1, 2024: Journal of Head Trauma Rehabilitation
https://read.qxmd.com/read/38652572/association-of-the-multi-biomarker-disease-activity-score-with-arterial-18-fluorodeoxyglucose-uptake-in-rheumatoid-arthritis
#5
JOURNAL ARTICLE
Jon T Giles, Daniel H Solomon, Katherine P Liao, Pamela M Rist, Zahi A Fayad, Ahmed Tawakol, Joan M Bathon
OBJECTIVES: Rheumatoid arthritis (RA) and atherosclerosis share many common inflammatory pathways. We studied whether a multi-biomarker panel for RA disease activity (MBDA) would associate with changes in arterial inflammation in an interventional trial. METHODS: In the TARGET Trial, RA patients with active disease despite methotrexate were randomly assigned to the addition of either a TNF inhibitor or sulfasalazine+hydroxychloroquine (triple therapy). Baseline and 24-week follow-up 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography scans were assessed for change in arterial inflammation measured as the maximal arterial target-to-blood background ratio of FDG uptake in the most diseased segment of the carotid arteries or aorta (MDS-TBRmax)...
April 23, 2024: Rheumatology
https://read.qxmd.com/read/38652565/renal-cell-carcinoma-histologic-subtypes-exhibit-distinct-transcriptional-profiles
#6
JOURNAL ARTICLE
Pedro Barata, Shuchi Gulati, Andrew Elliott, Hans J Hammers, Earle F Burgess, Benjamin A Gartrell, Sourat Darabi, Mehmet A Bilen, Arnab Basu, Daniel M Geynisman, Nancy A Dawson, Matthew R Zibelman, Tian Zhang, Shuanzeng Wei, Charles J Ryan, Elisabeth I Heath, Kelsey A Poorman, Chadi Nabhan, Rana R McKay
Molecular profiling of clear cell RCC (ccRCC) tumors of clinical trial patients has identified distinct transcriptomic signatures with predictive value, yet data in non-clear cell variants (nccRCC) are lacking. We examined the transcriptional profiles of RCC tumors representing key molecular pathways, from a multi-institutional, real-world patient cohort, including ccRCC (n = 508) and centrally-reviewed nccRCC (n = 149) samples. ccRCC had increased angiogenesis signature scores compared to the heterogeneous group of nccRCC tumors (mean z-score 0...
April 23, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38652547/multi-omics-characterization-of-esophageal-squamous-cell-carcinoma-identifies-molecular-subtypes-and-therapeutic-targets
#7
JOURNAL ARTICLE
Dengyun Zhao, Yaping Guo, Huifang Wei, Xuechao Jia, Yafei Zhi, Guiliang He, Wenna Nie, Limeng Huang, Penglei Wang, Kyle Vaughn Laster, Zhicai Liu, Jinwu Wang, Mee-Hyun Lee, Zigang Dong, Kangdong Liu
Esophageal squamous cell carcinoma (ESCC) is the predominant form of esophageal cancer and is characterized by an unfavorable prognosis. To elucidate the distinct molecular alterations in ESCC and investigate therapeutic targets, we performed a comprehensive analysis of transcriptomic, proteomic, and phosphoproteomic data derived from 60 paired treatment-naive ESCC and adjacent non-tumor tissue samples. Additionally, we conducted a correlation analysis to describe the regulatory relationship between transcriptomic and proteomic processes, revealing alterations in key metabolic pathways...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38652539/mirna-148a-containing-gmsc-derived-evs-modulate-treg-th17-balance-via-ikkb-nf-%C3%AE%C2%BAb-pathway-and-treat-a-rheumatoid-arthritis-model
#8
JOURNAL ARTICLE
Jingrong Chen, Xiaoyi Shi, Yanan Deng, Junlong Dang, Yan Liu, Jun Zhao, Liang Rongzhen, Donglan Zeng, Wenbin Wu, Yiding Xiong, Jia Yuan, Ye Chen, Julie Wang, Weidong Lin, Xiangfang Chen, Weishan Huang, Nancy Olsen, Yunfeng Pan, Qing-Ling Fu, Song Guo Zheng
Mesenchymal stem cells (MSCs) have demonstrated potent immunomodulatory properties that have shown promise in the treatment of autoimmune diseases, including rheumatoid arthritis (RA). However, the inherent heterogeneity of MSCs triggered conflicting therapeutic outcomes, raising safety concerns and limiting their clinical application. This study aimed to investigate the potential of extracellular vesicles derived from human gingival mesenchymal stem cells (GMSC-EVs) as a therapeutic strategy for RA. Through in vivo experiments using an experimental RA model, our results demonstrated that GMSC-EVs selectively homed to inflamed joints and recovered Treg and Th17 cells balance, resulting in the reduction of arthritis progression...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38652460/gastrointestinal-mucositis-a-sign-of-a-systemic-inflammatory-response
#9
JOURNAL ARTICLE
Nicole M A Blijlevens, Björn Reijnders, Eva Molendijk
PURPOSE OF REVIEW: Gastrointestinal mucositis (GIM) is a significant complication of cancer therapy. Whilst inflammation is a central feature of GIM, studies attempting to mitigate mucosal damage via this mechanism are scarce. This review describes the relation between GIM, local and systemic inflammation, and the microbiome and its metabolites, and explores recent research on therapeutics that target this relationship. RECENT FINDINGS: Recent literature underscores the pivotal role of inflammation in GIM, elucidating its bidirectional relation with disturbance of the gut microbiota composition and intestinal permeability...
April 23, 2024: Current Opinion in Supportive and Palliative Care
https://read.qxmd.com/read/38652430/quercetin-in-osteoporosis-treatment-a-comprehensive-review-of-its-mechanisms-and-therapeutic-potential
#10
REVIEW
Yanchen Feng, Xue Dang, Pan Zheng, Yali Liu, Diyan Liu, Zhiying Che, Jianping Yao, Zixuan Lin, Ziyun Liao, Xingyuan Nie, Feixiang Liu, Yunke Zhang
PURPOSE OF REVIEW: This review aims to provide a theoretical basis and insights for quercetin's clinical application in the prevention and treatment of osteoporosis (OP), analyzing its roles in bone formation promotion, bone resorption inhibition, anti-inflammation, antioxidant effects, and potential mechanisms. RECENT FINDINGS: OP, a prevalent bone disorder, is marked by reduced bone mineral density and impaired bone architecture, elevating the risk of fractures in patients...
April 23, 2024: Current Osteoporosis Reports
https://read.qxmd.com/read/38652355/recent-united-states-developments-in-the-pharmacological-treatment-of-dry-eye-disease
#11
REVIEW
David Valdés-Arias, Elyana V T Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Dry eye disease (DED) can arise from a variety of factors, including inflammation, meibomian gland dysfunction (MGD), and neurosensory abnormalities. Individuals with DED may exhibit a range of clinical signs, including tear instability, reduced tear production, and epithelial disruption, that are driven by different pathophysiological contributors. Those affected often report a spectrum of pain and visual symptoms that can impact physical and mental aspects of health, placing an overall burden on an individual's well-being...
April 23, 2024: Drugs
https://read.qxmd.com/read/38652345/global-untargeted-and-individual-targeted-plasma-metabolomics-of-breast-cancer-recurrence-modified-by-hormone-receptors
#12
JOURNAL ARTICLE
Pei-Jing Yang, Eing-Mei Tsai, Ming-Feng Hou, Yen-Jung Lee, Tsu-Nai Wang
BACKGROUND: Breast cancer is a heterogeneous and complex etiological disease. Understanding perturbations of circulating metabolites could improve prognosis. METHODS: We recruited breast cancer patients from Kaohsiung Medical University (KMU) to perform untargeted (case-control design) and targeted (patient cohort) metabolomics analyses in the discovery and validation phases to evaluate interaction effects between clinical factors and plasma metabolites using multivariable Cox proportional hazards model...
April 23, 2024: Breast Cancer: the Journal of the Japanese Breast Cancer Society
https://read.qxmd.com/read/38652277/arnicolide-d-a-multi-targeted-anticancer-sesquiterpene-lactone-preclinical-efficacy-and-mechanistic-insights
#13
REVIEW
Shivaprasad Shetty Mangalpady, Sheila I Peña-Corona, Fabiola Borbolla-Jiménez, Rajesh Kaverikana, Shobhitha Shetty, Vinayaka Babu Shet, Zainab M Almarhoon, Daniela Calina, Gerardo Leyva-Gómez, Javad Sharifi-Rad
Arnicolide D, a potent sesquiterpene lactone from Centipeda minima, has emerged as a promising anticancer candidate, demonstrating significant efficacy in inhibiting cancer cell proliferation, inducing apoptosis, and suppressing metastasis across various cancer models. This comprehensive study delves into the molecular underpinnings of Arnicolide D's anticancer actions, emphasizing its impact on key signaling pathways such as PI3K/AKT/mTOR and STAT3, and its role in modulating cell cycle and survival mechanisms...
April 23, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38652250/posterior-vascular-anatomy-of-the-encephalon-a-comprehensive-review
#14
REVIEW
Diego Morales-Roccuzzo, Mohammadmahdi Sabahi, Michal Obrzut, Edinson Najera, David Monterroso-Cohen, Shadi Bsat, Badih Adada, Hamid Borghei-Razavi
PURPOSE: This article presents a comprehensive exploration of neurovascular anatomy of the encephalon, focusing specifically on the intricate network within the posterior circulation and the posterior fossa anatomy; enhancing understanding of its dynamics, essential for practitioners in neurosurgery and neurology areas. METHOD: A profound literature review was conducted by searching the PubMed and Google Scholar databases using main keywords related to neurovascular anatomy...
April 23, 2024: Surgical and Radiologic Anatomy: SRA
https://read.qxmd.com/read/38652214/extracellular-vesicles-derived-from-bone-marrow-mesenchymal-stem-cells-ameliorate-chronic-liver-damage-via-microrna-136-5p
#15
JOURNAL ARTICLE
Xiaodan Jiang, Zhejun Liu, Hongjie You, Zuoqing Tang, Yun Ma, Ruifang Nie, Zheng Yang, Niancong Che, Wenlan Liu
Chronic liver damage (CLD) encompasses a spectrum of conditions and poses a significant global health challenge, affecting millions of individuals. Currently, there is a deficiency of clinically validated therapeutics with minimal side effects. Emerging evidence underscores the significant potential of extracellular vesicles derived from bone marrow mesenchymal stem cells (BMSC-EVs) as a promising therapeutic method for CLD. This study aimed to evaluate the influence of BMSC-EVs containing microRNA-136-5p (BMSC-EVs-miR-136-5p) on macrophage polarization during chronic liver injury and elucidate the mechanisms associated with the GNAS/PI3K/ERK/STAT3 axis...
April 23, 2024: Molecular and Cellular Biochemistry
https://read.qxmd.com/read/38652072/investigation-of-basolateral-targeting-micelles-for-drug-delivery-applications-in-polycystic-kidney-disease
#16
JOURNAL ARTICLE
Yi Huang, Ali Osouli, Jessica Pham, Valeria Mancino, Colette O'Grady, Taranatee Khan, Baishali Chaudhuri, Nuria M Pastor-Soler, Kenneth R Hallows, Eun Ji Chung
Autosomal dominant polycystic kidney disease (ADPKD) is a complex disorder characterized by uncontrolled renal cyst growth, leading to kidney function decline. The multifaceted nature of ADPKD suggests that single-pathway interventions using individual small molecule drugs may not be optimally effective. As such, a strategy encompassing combination therapy that addresses multiple ADPKD-associated signaling pathways could offer synergistic therapeutic results. However, severe off-targeting side effects of small molecule drugs pose a major hurdle to their clinical transition...
April 23, 2024: Biomacromolecules
https://read.qxmd.com/read/38652041/regulatory-role-of-cd39-and-cd73-in-tumor-immunity
#17
REVIEW
Nicole Kaplinsky, Kada Williams, Dean Watkins, Molly Adams, Laura Stanbery, John Nemunaitis
CD39 is the rate-limiting enzyme for the molecular signal cascade leading to the generation of ADP and adenosine monophosphate (AMP). In conjunction with CD73, CD39 converts adenosine triphosphate (ATP) to ADP and AMP, which leads to the accumulation of immunosuppressive adenosine in the tumor microenvironment. This review focuses on the role of CD39 and CD73 in immune response and malignant progression, including the expression of CD39 within the tumor microenvironment and its relationship to immune effector cells, and its role in antigen presentation...
April 23, 2024: Future Oncology
https://read.qxmd.com/read/38651848/the-association-between-hidradenitis-suppurativa-and-diet-an-update
#18
JOURNAL ARTICLE
Marko Belamarić, Joško Miše, Zrinka Bukvić Mokos
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful inflammatory lesions, predominantly affecting areas of the skin rich in apocrine glands, such as inguinal, axillary, submammary, and anogenital regions, with an estimated global prevalence between 1%-4%. The treatment of HS is challenging with various treatment modalities employed to control the disease. Since the condition is chronic and life-impairing, many patients have looked for ways to complement their conventional treatment procedures with non-medical interventions, among which dietary interventions have been of particular interest...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38651831/nk-like-cd8-t-cell-one-potential-evolutionary-continuum-between-adaptive-memory-and-innate-immunity
#19
JOURNAL ARTICLE
Qiulei Wang, Shaodan Chen, Zhenhong Guo, Sheng Xia, Minghui Zhang
CD8 T cells are crucial adaptive immune cells with cytotoxicity to fight against pathogens or abnormal self-cells via major histocompatibility complex class I-dependent priming pathways. The composition of the memory CD8 T cell pool is influenced by various factors. Physiological aging, chronic viral infection, and autoimmune diseases promote the accumulation of CD8 T cells with highly differentiated memory phenotypes. Accumulating studies have shown that some of these memory CD8 T cells also exhibit innate-like cytotoxicity and upregulate the expression of receptors associated with natural killer (NK) cells...
April 23, 2024: Clinical and Experimental Immunology
https://read.qxmd.com/read/38651688/-prostate-cancer-from-the-patients-perspective
#20
JOURNAL ARTICLE
Kent Lewén, Calle Waller, Henrik Grönberg, Ola Bratt
Prostate cancer is the most common cancer among Swedish men. To get this diagnose is not only a threat to the men's lives but also to their quality of life because the treatment often affects sexuality, bladder function and bowel function. It is therefore particularly problematic that the rehabilitation of men after treatment for prostate cancer often does not reach the standards set out in the national guidelines. Despite the past years' promotion of standardized cancer care pathways to speed up the process of investigating and treating cancer, the lead times for men who are being investigated for a suspicion of prostate cancer, or are waiting for a planned prostate cancer treatment, are the longest in Swedish cancer care...
April 23, 2024: Läkartidningen
keyword
keyword
101937
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.